Get all your news in one place.
100's of premium titles.
One app.
Start reading
Euronews
Euronews
Gabriela Galvin

Experimental daily pill found to aid weight loss in what could be alternative to jabs like Ozempic

An experimental once-daily pill appears to be effective at aiding weight loss and lowering blood sugar among people with type 2 diabetes, according to new data from the drugmaker Eli Lilly.

The medicine, called orforglipron, belongs to a class of blockbuster weight loss drugs known as glucagon-like peptide-1 (GLP-1) receptor agonists, which mimic a hormone that makes people feel full.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.